Emerging roles of microRNAs and other non-coding transcriptome in muscular dystrophies.
Non-coding RNA patterns in muscular dystrophies reveal new biomarkers and potential drug targets for these rare neurological conditions.
This review catalogs the non-coding RNA landscape in muscular dystrophies, mapping how miRNAs contribute to disease through failed myogenesis, structural instability, and signaling failure. These ncRNAs represent potential biomarker and therapeutic targets for rare neuromuscular diseases.
What the study was
- Study design
- Review
- Population
- Muscular dystrophy patients
- Category
- Genomics/Precision Medicine
- Maturity
- Exploratory
- Journal
- Inflammation and regeneration
Why it surfaced
Comprehensive ncRNA review for muscular dystrophies. Review limits novelty but addresses rare disease unmet need.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.